Patent ID: 6491925
Filing Date: 2002-12-10
Classification: A61K

Abstract:
An immunogenic composition comprising:a) a tumor cell membrane preparation wherein said tumor cell in nature lacks an immunological costimulatory cell surface molecule (CoCAM), and wherein said tumor cell membrane has been modified by the introduction of a glycosylated phosphatidylinositol (GPI)-anchored B7-1 fusion protein with the result that said tumor cell membrane preparation comprises said glycosylated phosphatidylinositol-anchored B7-1 fusion protein stably incorporated, wherein a DNA molecule encoding the B7-1 portion of the fusion protein is amplified using a human B7-1 clone and primers having the nucleotide sequences provided in SEQ ID NO:1 and SEQ ID NO:2 and wherein a DNA molecule encoding a GPI anchor signal portion is amplified using a human CD16B cDNA clone and primers having the nucleotide sequences provided in SEQ ID NO:3 and SEQ ID NO:4 and wherein the DNA molecules were annealed using a polymerase chain amplification reaction and primers having the nucleotide sequences provided in SEQ ID NO:1 and SEQ ID NO:4; b) a pharmaceutically acceptable carrier; and c) at least one cytokine in an amount effective for augmenting an immune response.